HedgeChatter

  • Home /
  • Tag Archives

cmp

Compass Minerals Updates Guidance at the BMO Capital Markets 2014 Global Metals and Mining Conference

[Business Wire] – Compass Minerals announced today that the company’s chief financial officer, Rodney Underdown, will be attending the BMO Capital Markets 2014 Global Metals and Mining Conference in Hollywood, Fla., beginning Monday, February 24. moreView todays social media effects on CMPView the latest stocks trending across Twitter. Click to view dashboardSee who Compass is hiring next, click here to […]

February 24, 2014 Bystocknews , Comments Off on Compass Minerals Updates Guidance at the BMO Capital Markets 2014 Global Metals and Mining Conference read more

Compass Minerals International’s CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Francis Malecha Thank you, Theresa. And thank you all for joining us today to discuss Compass Minerals’ fourth quarter performance and outlook for 2014. Today, we’re reporting both topline and bottomline … moreView todays social media effects on CMPView the latest stocks trending across Twitter. Click to view dashboardSee who Compass is hiring next, click here […]

February 11, 2014 Bystocknews , Comments Off on Compass Minerals International’s CEO Discusses Q4 2013 Results – Earnings Call Transcript read more

4:22 pm Compass Minerals Intl reports Q4 results

moreView todays social media effects on CMPView the latest stocks trending across Twitter. Click to view dashboardSee who Compass is hiring next, click here to view […]

February 10, 2014 Bystocknews , Comments Off on 4:22 pm Compass Minerals Intl reports Q4 results read more

Stocks in News: Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) made a new 52-week high of $16.38 today on traded volume of 1.02 million shares. The development-stage pharmaceutical company recently announced positive results from a clinical trial of its oral insulin capsule in type 1 diabetes patients. ORMP shares are trading in the range of $11.38 to $16.38 in the current trading session. The company has […]

December 24, 2013 ByHedgeChatter , , , , , , , , , , Comments Off on Stocks in News: Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) read more